Previous studies on molecular profiling of lipomatous tumors have established amplification of MDM2 as a diagnostic marker distinguishing WDLPS and DDLPS from benign lipomatous tumors as well as other subtypes of liposarcoma (9, 10). The gene discussed is MDM2; the disease is dedifferentiated liposarcoma.